Back to STATE STREET CORP STATE STREET CORP

MREOMREO
8 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in MEREO BIOPHARMA GROUP PLC

STATE STREET CORP holds 134,772 shares of MREO (MEREO BIOPHARMA GROUP PLC), worth $42,817 as of 2026-Q2. The position was increased (+1.0% shares).

Current Value

$42,817

Current Shares

134,772

Total Value Change

-$152,659

Total Shares Change

+87,211

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
134,772
+1.0%
$42,8170.0%$0.32
14
2026-Q1
Increased
133,379
+2.1%
$44,0150.0%$0.41
14
2025-Q4
Decreased
130,643
-1.6%
$54,4390.0%$0.37
0
2025-Q3
Increased
132,701
+195.3%
$273,3640.0%$1.96
26
2025-Q2
Decreased
44,942
-1.6%
$121,7930.0%$2.66
0
2025-Q1
Decreased
45,659
-3.0%
$102,7330.0%$2.30
0
2024-Q4
Decreased
47,085
-1.0%
$164,7980.0%$3.52
0
2024-Q3
New
47,561
-
$195,4760.0%$4.14
35

Other major holders of MREO: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used